Literature DB >> 16406988

Biological correlates of p27 compartmental expression in prostate cancer.

Rile Li1, Thomas M Wheeler, Hong Dai, Mohammad Sayeeduddin, Peter T Scardino, Anna Frolov, Gustavo E Ayala.   

Abstract

PURPOSE: As one of the cyclin-dependent kinase inhibitors, p27 has been associated with biological behavior and disease progression in malignancies.
MATERIALS AND METHODS: Tissue microarrays were constructed using 640 radical prostatectomy specimens. Normal prostate tissue, benign prostatic hyperplasia and index tumor were cored in triplicate at 0.6 mm. Slides were stained with an antibody to p27 and digitized. The expression of p27 was quantified. SPSS 11.0 (SPSS, Chicago, Illinois) was used to perform the Spearman correlation test, Kaplan-Meier analysis and Cox proportional hazard regression.
RESULTS: We noted p27 expression predominately located in the epithelial nuclei of benign and cancer tissues. In PCa p27 was decreased compared to that in normal tissue, while p27 cytoplasmic expression was increased in PCa. Moderate nuclear p27 and cytoplasmic displacement of p27 were associated with worse disease-free survival compared with high or low p27. The cytoplasmic presence of p27 was an independent indicator for predicting the probability of biochemical recurrence in PCa.
CONCLUSIONS: We report that p27 expression is consistently high in the normal prostate. Moderate levels of nuclear p27 and/or cytoplasmic entrapment of p27 are associated with increased proliferation and worse biochemical recurrence-free survival. These findings suggest that PCa may enhance its growth and progression by decreasing nuclear p27 via cytoplasmic displacement and other molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406988     DOI: 10.1016/S0022-5347(05)00151-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Authors:  Michelle D Larrea; Feng Hong; Seth A Wander; Thiago G da Silva; David Helfman; Deborah Lannigan; Jeffrey A Smith; Joyce M Slingerland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

2.  Expression of ERG protein in prostate cancer: variability and biological correlates.

Authors:  Gustavo Ayala; Anna Frolov; Deyali Chatterjee; Dandan He; Susan Hilsenbeck; Michael Ittmann
Journal:  Endocr Relat Cancer       Date:  2015-06       Impact factor: 5.678

3.  Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays.

Authors:  Viju Ananthanarayanan; Ryan J Deaton; Anup Amatya; Virgilia Macias; Ed Luther; Andre Kajdacsy-Balla; Peter H Gann
Journal:  Hum Pathol       Date:  2011-02-02       Impact factor: 3.466

Review 4.  p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

Authors:  Seth A Wander; Dekuang Zhao; Joyce M Slingerland
Journal:  Clin Cancer Res       Date:  2010-10-21       Impact factor: 12.531

Review 5.  The AR dependent cell cycle: mechanisms and cancer relevance.

Authors:  Matthew J Schiewer; Michael A Augello; Karen E Knudsen
Journal:  Mol Cell Endocrinol       Date:  2011-07-12       Impact factor: 4.102

6.  Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype.

Authors:  Srirupa Roy; Rana P Singh; Chapla Agarwal; Sunitha Siriwardana; Robert Sclafani; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2008-06-30       Impact factor: 4.534

7.  Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.

Authors:  S Wen; Y So; K Singh; J M Slingerland; M B Resnick; S Zhang; V Ruiz; S F Moss
Journal:  Oncogene       Date:  2011-08-15       Impact factor: 9.867

8.  Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.

Authors:  D Zhao; A H Besser; S A Wander; J Sun; W Zhou; B Wang; T Ince; M A Durante; W Guo; G Mills; D Theodorescu; J Slingerland
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

Review 9.  The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.

Authors:  Naveen Kachroo; Vincent J Gnanapragasam
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-28       Impact factor: 4.553

10.  The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner.

Authors:  S T Charette; D J McCance
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.